Genetic Biomarker Predicts Taxane-induced Neuropathy

A new study has identified the first genetic biomarkers for taxane-induced peripheral neuropathy, a potentially severe complication of taxane chemotherapy. Dr. Bryan Schneider, lead author and a physician/researcher at the Indiana University Melvin and Bren Simon Cancer Center, said, “This may allow for better counseling, use of alternative drugs or schedules, or omission of taxane in the appropriate settings….” READ MORE

Source: Medscape

Join us in improving the lives of peripheral neuropathy patients.
Send this to a friend